| abstract |
Novel selenophene compounds useful as anti-tumor agents are described. Preferred compounds include compounds of formula I: n n nwherein R 1 and R 2 are independently selected from the group consisting of n n nH, CHO, CH 2 OH, and CH 2 NH 2 ; and n X and Y are independently selected from the group consisting of Se, S, O, NCH 3 , and NH. Pharmaceutical compositions and a method for treating patients having tumors utilizing the disclosed selenophene compounds are also described. |